Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
0.8633
-0.0263 (-2.96%)
Nov 3, 2025, 4:00 PM EST - Market closed
Atossa Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts that cover Atossa Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $6.25, which forecasts a 623.97% increase in the stock price over the next year. The lowest target is $4.00 and the highest is $7.75.
Price Target: $6.25 (+623.97%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 22, 2025.
Analyst Ratings
The average analyst rating for Atossa Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7.5 → $7.75 | Strong Buy | Maintains | $7.5 → $7.75 | +797.72% | Sep 22, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7.25 → $7.5 | Strong Buy | Maintains | $7.25 → $7.5 | +768.76% | Jun 6, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +363.34% | Jun 5, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7 → $7.25 | Strong Buy | Maintains | $7 → $7.25 | +739.80% | Apr 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +710.84% | Mar 26, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.25
from -0.20
EPS Next Year
-0.28
from -0.25
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.24 | -0.27 | |||
| Avg | -0.25 | -0.28 | |||
| Low | -0.25 | -0.30 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.